Summary
This 8-K filing by CME Group Inc. (CME) reports on an amendment to its existing 364-day revolving Bridge Credit Facility. The primary purpose of the amendment, effective December 10, 2007, is to expand the permissible uses of the loan proceeds. Previously established as a backstop for CME's commercial paper program, the facility's scope has been broadened to include financing a proposed equity investment of up to 10% in the Brazilian Mercantile & Futures Exchange S.A. ("BM&F"), along with related transaction costs.
Key Highlights
- 1CME Group amended its 364-day revolving Bridge Credit Facility, originally for $3.0 billion and subsequently reduced to $750 million.
- 2The amendment, dated December 10, 2007, allows the facility to be used for financing a potential 10% equity investment in the Brazilian Mercantile & Futures Exchange S.A. (BM&F).
- 3Proceeds can also be used for costs associated with a prior fixed price tender offer and the merger with CBOT Holdings, Inc.
- 4The facility can support commercial paper for these transactions.
- 5Up to $300 million of the facility can be used for general corporate purposes.
- 6The filing incorporates by reference the details of the amendment and related exhibits.
Frequently Asked Questions
The primary change is the expansion of the facility's use of proceeds to include financing a proposed up to 10% equity investment in the Brazilian Mercantile & Futures Exchange S.A. (BM&F), in addition to its existing uses for commercial paper support, prior merger/tender offer expenses, and general corporate purposes.
The Bridge Credit Facility initially provided for revolving loans of up to $3.0 billion. Following previous actions, the commitment was decreased to $750 million. The amendment does not indicate a change to this $750 million limit, only its permissible uses.
While the 8-K filing itself does not provide strategic details, the inclusion of BM&F financing within the credit facility suggests that this potential investment is a significant initiative for CME Group, indicating an expansion into international markets or strategic partnerships.
This filing primarily concerns an amendment to an existing financial obligation (the Bridge Credit Facility). It does not create a new, separate direct financial obligation in itself, but rather modifies the terms and uses of the existing one.